Rapid Response, No Ultracold: China Sees Global Opening For Vaccine Supplies
Lower Costs Another Benefit?
SinoVac’s rapid antibody response, CanSino’s easier logistics requirements - plus cost advantages - make Chinese developers optimistic about supplying the world with COVID vaccines.
